Liquid Biopsy in Breast Cancer

Abstract

Breast cancer (BC) to date remains the most common cancer in women [1]. The increased incidence is due to wide intro duction of mammography screening programs and continues to grow with the aging of the popu lation, while the prevalence is increasing as a consequence of improvements in treatment out comes. At the same time, mortality has decreased thanks to an efficient screening that enables dis ease diagnosis at a very early stage. Moreover, chemotherapy and endocrine adjuvant therapy have strongly implemented treatment in BC.